收藏本站万方检测维普检测中文降重英文语法检测 Turnitin UK版 Turnitin 国际版

登录注册

文献互助

发帖

版主：xxs1234, 1127761702, MRQ, 猜才彩蔡, 1764992075, ARomeo

主题分类：

↓ 下拉展示

新窗全部主题最新热门热帖精华更多

1回复

qazwsx2431 昨天 17:13

10 Phase I/II Study of Bavdegalutamide, a Proteolysis-Targeting Chimera Androgen Receptor Degrader, in Metastatic Castration-Resistant Prostate Cancer

ASCO
0回复

alandan 3 天前

10 Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in TP53-Mutated Diffuse Large B-Cell Lymphoma.

ASCO
1已完成

total18 4 天前

10 Identifying Oncology Clinical Trial Candidates Using Artificial Intelligence Predictions of Treatment Change: A Pilot Implementation Study

ASCO
1已完成

jiejiejie 4 天前

10 Fidelity of Next-Generation Sequencing to Predict Human Epidermal Growth Factor 2 Overexpression Across Solid Tumors

ASCO
2已完成

fyq19951102 4 天前

10 Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma

ASCO
1已完成

zzdxdyffyy 4 天前

10 Accuracy of Computed Tomography Staging of Mismatch Repair-Deficient Colon Cancer

ASCO
0回复

guan1901 5 天前

10 Phase II, Randomized, Open-Label Study of Pegfilgrastim-Supported VDC/IE Chemotherapy in Pediatric Sarcoma Patients

ASCO
1已完成

Mopey 2026-10-23

10 Total Neoadjuvant Therapy With Long-Course Radiotherapy Versus Chemoradiotherapy in High-Risk Locally Advanced Rectal Cancer (TNTCRT): A Multicenter, Randomized, Phase III Trial

ASCO
0回复

guan1901 2026-10-23

10 Phase II, Randomized, Open-Label Study of Pegfilgrastim-Supported VDC/IE Chemotherapy in Pediatric Sarcoma Patients

ASCO
1已完成

lirunze 2026-10-22

10 Association of Circulating Eosinophils With Systemic Immune Activation and Reduced Recurrence in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer

ASCO
1已完成

inn35579 2026-10-19

20 The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease

ASCO
0回复

MOON-59 2026-10-18

10 First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826

ASCO
1已完成

alandan 2026-10-17

10 B7-H3 as a Universal Target for Solid Tumor Therapy: Clinical Promise and Biological Complexity

ASCO
1已完成

lillix 2026-10-12

10 Camrelizumab Plus Famitinib versus Camrelizumab Alone and Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer: A Randomized, Phase II Study

ASCO
1已完成

JasonZheng 2026-10-12

10 Pathologic Lymph Node Regression After Neoadjuvant Chemotherapy Predicts Recurrence and Survival in Esophageal Adenocarcinoma: A Multicenter Study in the United Kingdom

ASCO
1已完成

lillix 2026-10-11

10 Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy Update

ASCO
1已完成

zzdxdyffyy 2026-10-10

10 Accuracy of Computed Tomography Staging of Mismatch Repair-Deficient Colon Cancer

ASCO
1已完成

wudaoxiang 2026-10-8

10 Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001)

ASCO
1已完成

hdbys 2026-10-8

30 EXTENDing the Role of Radiation in Oligometastatic Disease

ASCO
1已完成

zhangcx75 2026-10-3

10 HER2-Low Breast Cancer: Pathological and Clinical Landscape

ASCO

12 3 4 5 6 7 8 9 10 ... 19 / 19 页下一页

悬赏问答

最新回复

站点公告

今日热心研友

（热心研友QQ群）

Powered by 谷粉学术社区X3.4 Copyright © 2001-2025.

湘ICP备2021017706号

深度AI学术|深度AI学术搜索|AI科研狗|小黑屋|版权归属及声明|